Inventor · disambiguated record
Alexander M. Depaoli
Also filed as: DEPAOLI ALEXANDER · DEPAOLI ALEXANDER M · DEPAOLI ALEXANDER MARK
4 granted patents·12 pending applications·42 citations·filing 2003–2024
77Inventor score
Top patents by PatentIndex Score
16 records- 0195US10434144B2Methods for treatment of bile acid-related disorders and prediction of clinical sensitivity to treatment of bile acid-related disordersNGM BIOPHARMACEUTICALS INC·Filed 2015·Granted Oct 8, 2019·11 cites·9 claims
- 0286US7183254B2Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatmentAMGEN INC·Filed 2003·Granted Feb 27, 2007·26 cites·30 claims
- 0381US11141460B2Methods for treatment of bile acid-related disorders and prediction of clinical sensitivity to treatment of bile acid-related disordersNGM BIOPHARMACEUTICALS INC·Filed 2019·Granted Oct 12, 2021·1 cites·10 claims
- 0475US8318666B2Use of leptin to treat metabolic abnormalities associated with lipoatrophyDEPAOLI ALEXANDER M·Filed 2011·Granted Nov 27, 2012·4 cites·35 claims
- 0572US2022072099A1Methods for treatment of bile acid-related disorders and prediction of clinical sensitivity to treatment of bile acid-related disordersNGM BIOPHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0666US2020268853A1Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatmentAMGEN INC·Filed 2020·Application pending·0 cites
- 0764US2025074991A1Methods of treating nausea and vomiting disorders using anti-gfral antibodiesNGM BIOPHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0863US2019321447A1Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatmentAMGEN INC·Filed 2018·Application pending·0 cites
- 0960US2023107304A1Methods of treating cancer and tumor-related weight loss and cachexiaNGM BIOPHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1058US2007099836A1Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatmentUNIV TEXAS·Filed 2006·Application pending·0 cites
- 1156US2017095535A1Use of leptin for treating human lipoatrophy and method for determining predisposition to said treatmentAMGEN INC·Filed 2016·Application pending·0 cites
- 1255US2014294866A1Uses of Myostatin AntagonistsAMGEN INC·Filed 2014·Application pending·0 cites
- 1355US2007149458A1Uses of myostatin antagonistsAMGEN INC·Filed 2006·Application pending·0 cites
- 1452US2013190225A1Use of Leptin for Treating Human Lipoatrophy and Method of Determining Predisposition to Said TreatmentDEPAOLI ALEXANDER M·Filed 2012·Application pending·0 cites
- 1548US2020390858A1Combination Therapy for Modulating Bile Acid Homeostasis and Treatment of Bile Acid Disorders and DiseasesNGM BIOPHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1645US2011008375A1Uses of Myostatin AntagonistsAMGEN INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alexander M. Depaoli files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →